|
ID2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.442000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.803000E-03 |
| Normal-vs-Stage2 |
6.638000E-01 |
| Normal-vs-Stage3 |
3.872200E-01 |
| Normal-vs-Stage4 |
1.399850E-01 |
| Stage1-vs-Stage2 |
3.242400E-01 |
| Stage1-vs-Stage3 |
7.868400E-01 |
| Stage1-vs-Stage4 |
3.861900E-03 |
| Stage2-vs-Stage3 |
6.053200E-01 |
| Stage2-vs-Stage4 |
2.178400E-01 |
| Stage3-vs-Stage4 |
1.232440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.294100E-02 |
| Normal-vs-AfricanAmerican |
6.070100E-02 |
| Normal-vs-Asian |
5.388400E-01 |
| Caucasian-vs-AfricanAmerican |
4.921600E-01 |
| Caucasian-vs-Asian |
9.026400E-01 |
| AfricanAmerican-vs-Asian |
9.135800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.054500E-02 |
| Normal-vs-Female |
2.029700E-02 |
| Male-vs-Female |
1.928820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.960400E-01 |
| Normal-vs-Extreme_Weight |
5.932000E-02 |
| Normal-vs-Obese |
5.702300E-02 |
| Normal-vs-Extreme_Obese |
5.872400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.342000E-01 |
| Normal_Weight-vs-Obese |
4.877600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.697600E-01 |
| Extreme_Weight-vs-Obese |
8.974400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.565600E-01 |
| Obese-vs-Extreme_Obese |
8.009400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.027400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.388400E-04 |
| Normal-vs-Age(61-80Yrs) |
3.995400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.047640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.235400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.860400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.145900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.939400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.379200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.743900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.57236999999144E-05 |
| Normal-VS-Type2 PRCC |
2.587200E-01 |
| Normal-VS-KIRP CIMP |
2.002300E-03 |
| Normal-VS-Unclassified PRCC |
5.869200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.172190E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.89230000014318E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.332400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.725000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.411000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.626350E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.121600E-01 |
| Normal-vs-N1 |
7.402000E-01 |
| Normal-vs-N2 |
2.28439999999663E-05 |
| N0-vs-N1 |
8.302200E-01 |
| N0-vs-N2 |
3.88360000047605E-07 |
| N1-vs-N2 |
1.206020E-02 |
|
|
